EUVIMED · CrossrefZeitschrift
Orphanet Journal of Rare Diseases
ISSN 1750-1172 · Springer Science and Business Media LLC
Neueste Artikel
Deep phenotyping in medical genetics and genomics: a comprehensive overview
Evaluation of patients affected by inherited metabolic disorders (IMDs) in adult centres: a snapshot from the first multi-centre Italian survey from the Italian society for the study of hereditary metabolic diseases and newborn screening (SIMMESN) adult metabolic working group
Bezafibrate partially rescues mitochondrial dysfunction in NDUFAF2-deficient cellular and rotenone-induced models of complex I impairment
Functional characterization of novel compound heterozygous SLC12A3 mutations in a patient with Gitelman syndrome
Addressing data fragmentation and drug development barriers in primary mitochondrial diseases: the C-Path Primary Mitochondrial Diseases (PMD) Task Force approach to data harmonization, integration, and endpoint development
Glycerol phenylbutyrate as an effective chemical chaperone for traffic-defective ABCB4 variants: comparative analysis with 4-phenylbutyrate
Qualitative insights from partners of individuals with Huntington’s disease: the quality of life of an under-researched population
Blood biomarkers associated with hamartomatous lesions in tuberous sclerosis complex: a scoping review
A deep intronic splicing mutation in LAMB3 causes systemic inflammation in severe junctional epidermolysis bullosa amenable to targeted therapy
Immunofluorescence mapping vs. electron microscopy in epidermolysis bullosa: comparative retrospective study in 84 genetically confirmed patients
Validation of the 7-day FABPRO-GI questionnaire in Turkish Fabry disease patients
Phenotypic spectrum and diagnostic evolution in GLUT1 deficiency syndrome: a single-centre adult cohort experience
A home for rare disease: the creation of the NORD centers of excellence
Establishing The Australian Undiagnosed Diseases Network (UDN-Aus); Australia’s first national rare disease diagnostic network
Patient-reported experiences of people living with a rare disease with secondary and tertiary care: a scoping review
Living with dystrophic epidermolysis bullosa in Poland: first national study of health-related quality of life and symptom burden
Patient perspectives on European Reference Networks: supporting a flagship initiative through lived experience
Overlooked brain injury manifesting as diplopia in Wilson disease
Monitoring disease progression in fabry disease: insights from a structured nominal expert consensus
Letter to the Editor in response to article: Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical team
Genetic spectrum, retinal phenotypes, and visual function in female carriers of RPGR
Pregnancy in women with inherited metabolic disorders: maternal and offspring outcomes with long-term follow-up
Comparison of the relationship between oral findings and salivary parameters and DMFT in patients with lipoid proteinosis and healthy individuals: a case-control study
Post-marketing vascular ectasia and regional bleeding reports with sotatercept in pulmonary arterial hypertension: a disease-restricted active-comparator pharmacovigilance study
Urinary mevalonate excretion: a specific and sensitive screening test for mevalonate kinase deficiency
Study of COVID-19 outcomes in patients with rare diseases in Germany [SCOPE-RD], part 2
Six Chinese children with type 2 congenital generalized lipodystrophy: clinical features and follow-up
Clinical trials on rare diseases in Austria 2011–2021: a study using the orphanet database
X-linked chondrodysplasia punctata 1 (CDPX1) due to ARSL pathogenic variants and Xp22.33 contiguous gene deletions: a narrative review of genetics, clinical phenotype, neurodevelopmental features, diagnosis, and multidisciplinary management
Overcoming the challenges of rare disease clinical research
EUVIMED